News

Terry Smith slammed two of Denmark’s largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they ...
Exploring the Strategic Adjustments in the Fund's Portfolio. Invesco EQV European Equity Fund (Trades, Portfolio) recently ...
Coloplast A/S is acquiring Kerecis hf, a closely held Icelandic maker of fish-skin dressings to treat human wounds, for an enterprise value of up to $1.3 billion.
Coloplast has agreed to buy Iceland-based Kerecis, a biologic wound care firm that uses fish skin to develop tissue-transplant products, for up to $1.3 billion, the Danish medical equipment maker ...
Coloplast is absolutely a high-quality med-tech growth story and is worthy of a premium. Unfortunately, even with an advantageous discount rate, the shares are not cheap on discounted cash flow.
Coloplast delivered Q4 organic growth of 8% and an EBIT margin 1 of 26%, which was negatively impacted by extraordinary costs and currencies. Reported revenue in DKK grew 12% with 3%- pts ...
Coloplast A/S. The event will take place on Thursday, 6 June 2024 at Coloplast’s Headquarters Holtedam 3, 3050 Humlebaek, Denmark from 11.30 - 18.00 CEST (Central European Summer Time ...
Coloplast A/S, the Danish maker of medical products, agreed to pay about $16 million to settle lawsuits over claims it injured women with its vaginal-mesh inserts, three people familiar with the ...
View the latest Coloplast A/S ADR (CLPBY) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Coloplast delivered 8% organic growth and an EBIT margin 1 of 27% in Q1, in line with expectations. In December 2024, Coloplast divested its Skin Care portfolio to simplify business operations and ...
Coloplast's ownership structure favors the holders of A shares (mainly the Louis-Hansen founding family), which holds 44% of the equity but retains 68% of the voting power.
Coloplast's ownership structure favors the holders of A shares (mainly the Louis-Hansen founding family), which holds 44% of the equity but retains 68% of the voting power.